Register today for a LIVE national broadcast on New Treatment Options for Rare Diseases in the Soft Tissue for March 5th and 6th!

News >

FDA Approves Vemurafenib for Rare Blood Cancer

Silas Inman @silasinman
Published: Monday, Nov 06, 2017

Richard Pazdur, MD

Richard Pazdur, MD
The FDA has approved vemurafenib (Zelboraf) as a treatment for patients with BRAF V600-mutated Erdheim-Chester disease (ECD), representing the first approved therapy for this rare blood disorder.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication